{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.9","upperLimit":"47","value":"20.9"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"description":"survival was evaluated q 2months","dispersionType":"95% Confidence Interval","groups":[{"description":"Rituximab administered at a dose of 375mg/m2 as a single IV infusion every week for up to 8 weeks","id":"OG000","title":"Rituximab Monotherapy"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"47 months","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"months"}